Krisztina M. Zsebo - Apr 14, 2022 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role
Director
Signature
/s/ David McClung, by power of attorney
Stock symbol
BCDA
Transactions as of
Apr 14, 2022
Transactions value $
$0
Form type
4
Date filed
5/12/2023, 08:21 PM
Previous filing
Jun 15, 2021
Next filing
Sep 30, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCDA Stock Option (right to buy) Award $0 +31.1K +125% $0.00 56K Apr 14, 2022 Common stock 31.1K $1.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to one-third of the shares on December 22, 2021 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Remarks:

This Form 4 is late due to an inadvertent administrative error.